Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
7.74
+0.59 (8.25%)
At close: Jun 26, 2026, 4:00 PM EDT
7.60
-0.14 (-1.81%)
After-hours: Jun 26, 2026, 7:33 PM EDT
Entrada Therapeutics Market Cap
Entrada Therapeutics has a market cap or net worth of $278.9 million as of June 26, 2026. Its market cap has increased by 0.13% in one year.
Market Cap
278.90M
Enterprise Value
73.79M
1-Year Change
0.13%
Ranking
Category
Stock Price
$7.74
Market Cap Chart
Since the IPO on October 29, 2021, Entrada Therapeutics's market cap has increased from $251.01M to $278.90M, an increase of 11.11%. That is a compound annual growth rate of 2.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 278.90M | -24.35% |
| Dec 31, 2025 | 368.66M | -39.78% |
| Dec 31, 2024 | 612.16M | 21.70% |
| Dec 29, 2023 | 503.01M | 18.72% |
| Dec 30, 2022 | 423.70M | -20.71% |
| Dec 31, 2021 | 534.36M | 112.88% |
| Oct 29, 2021 | 251.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Greenwich LifeSciences | 290.63M |
| SAB Biotherapeutics | 290.56M |
| Zentalis Pharmaceuticals | 287.59M |
| Bicycle Therapeutics | 286.23M |
| InflaRx | 282.80M |
| Adagene | 278.17M |
| Cartesian Therapeutics | 276.77M |
| ALX Oncology Holdings | 274.51M |